A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)

This study has been completed.

Study NCT00049777 Information provided by Eli Lilly and Company

First Received: November 13, 2002 Last Updated: January 24, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2005
Estimated Primary Completion Date:	No date given